BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rampone B, Schiavone B, Confuorto G. Current management of hepatocellular cancer. Curr Oncol Rep 2010;12:186-92. [PMID: 20425078 DOI: 10.1007/s11912-010-0094-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Kohla MA, Abu Zeid MI, Al-Warraky M, Taha H, Gish RG. Predictors of hepatic decompensation after TACE for hepatocellular carcinoma. BMJ Open Gastroenterol 2015;2:e000032. [PMID: 26462282 DOI: 10.1136/bmjgast-2015-000032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
2 Zhang Y, Zheng K, Yan H, Jin G, Shao C, Zhou X, Zhou Y, He T. Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma. BMC Gastroenterol 2014;14:62. [PMID: 24708487 DOI: 10.1186/1471-230X-14-62] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Piccioni F, Malvicini M, Garcia MG, Rodriguez A, Atorrasagasti C, Kippes N, Piedra Buena IT, Rizzo MM, Bayo J, Aquino J, Viola M, Passi A, Alaniz L, Mazzolini G. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Glycobiology 2012;22:400-10. [DOI: 10.1093/glycob/cwr158] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 5.7] [Reference Citation Analysis]
4 Buijs N, Oosterink JE, Jessup M, Schierbeek H, Stolz DB, Houdijk AP, Geller DA, van Leeuwen PA. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1. Angiogenesis 2017;20:557-65. [PMID: 28741166 DOI: 10.1007/s10456-017-9567-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
5 Tomoda T, Nouso K, Miyahara K, Kobayashi S, Kinugasa H, Toyosawa J, Hagihara H, Kuwaki K, Onishi H, Nakamura S. Prognotic impact of serum follistatin in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2013;28:1391-1396. [PMID: 23432377 DOI: 10.1111/jgh.12167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
6 Muhi A, Ichikawa T, Motosugi U, Sano K, Fatima Z, Matsuda M, Fujii H, Enomoto N, Araki T. Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy. Hepatol Int 2013;7:662-8. [PMID: 26201799 DOI: 10.1007/s12072-012-9383-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Zhao H, Zhai X, Chen Z, Wan X, Chen L, Shen F, Ling C. Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma. Oncotarget 2017;8:45234-41. [PMID: 28423370 DOI: 10.18632/oncotarget.16804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Attallah AM, El-far M, Malak CAA, Omran MM, Shiha GE, Farid K, Barakat LA, Albannan MS, Attallah AA, Abdelrazek MA, Elbendary MS, Sabry R, Hamoda GA, Elshemy MM, Ragab AA, Foda BM, Abdallah SO. HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma. Tumor Biol 2015;36:7667-74. [DOI: 10.1007/s13277-015-3501-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
9 Yan W, Han P, Zhou Z, Tu W, Liao J, Li P, Liu M, Tian D, Fu Y. Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness. Dig Dis Sci 2014;59:1213-21. [PMID: 24442237 DOI: 10.1007/s10620-013-3016-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
10 Zhang QB, Jia QA, Wang H, Hu CX, Sun D, Jiang RD, Zhang ZL. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis. BMC Cancer 2016;16:880. [PMID: 27836008 DOI: 10.1186/s12885-016-2883-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
11 Zhang L, Jiang G, Yao F, Liang G, Wang F, Xu H, Wu Y, Yu X, Liu H. Osthole promotes anti-tumor immune responses in tumor-bearing mice with hepatocellular carcinoma. Immunopharmacol Immunotoxicol 2015;37:301-7. [PMID: 25975579 DOI: 10.3109/08923973.2015.1035391] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
12 Bi MR, Zhu LY, Yan BZ, Chen LY, Wang FX, Ma YJ, Yang BS. Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression. Hepat Mon 2014;14:e23552. [PMID: 25685165 DOI: 10.5812/hepatmon.23552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Kim R, Menon N, Aucejo F. Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection. Med Oncol 2011;28:1044-7. [DOI: 10.1007/s12032-010-9625-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Hu X, Bao M, Huang J, Zhou L, Zheng S. Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma. Front Oncol 2020;10:541479. [PMID: 33102213 DOI: 10.3389/fonc.2020.541479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Shu G, Zhao W, Yue L, Su H, Xiang M. Antitumor immunostimulatory activity of polysaccharides from Salvia chinensis Benth. Journal of Ethnopharmacology 2015;168:237-47. [DOI: 10.1016/j.jep.2015.03.065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
16 Attallah AM, El-far M, Malak CAA, Omran MM, Farid K, Yahya RS, Saad EA, Albannan MS, Attallah AA, El Basuni MA, Ali IS, Abed SB, El Naggar MA. A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma. Annals of Hepatology 2015;14:869-80. [DOI: 10.5604/16652681.1171774] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
17 Liu F, He Y, Liang Y, Wen L, Zhu Y, Wu Y, Zhao L, Li Y, Mao X, Liu H. PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinoma. Cancer Cell Int 2013;13:108. [PMID: 24176221 DOI: 10.1186/1475-2867-13-108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
18 Wu B, Yuan Y, Liu J, Shang H, Dong J, Liang X, Wang D, Chen Y, Wang C, Zhou Y, Jing H, Cheng W. Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma. J Nanobiotechnology 2021;19:177. [PMID: 34118951 DOI: 10.1186/s12951-021-00923-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tang Y, Zeng X, He F, Liao Y, Qian N, Toi M. Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Med Oncol 2012;29:977-84. [PMID: 21416157 DOI: 10.1007/s12032-011-9900-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
20 Rajiu V, Balaji P, Sheena TS, Akbarsha MA, Jeganathan K. Doxorubicin-Anchored Curcumin Nanoparticles for Multimode Cancer Treatment against Human Liver Carcinoma Cells. Part Part Syst Charact 2015;32:1028-42. [DOI: 10.1002/ppsc.201500098] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hur W, Ryu JY, Kim HU, Hong SW, Lee EB, Lee SY, Yoon SK. Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133. Sci Rep 2017;7:45557. [PMID: 28367990 DOI: 10.1038/srep45557] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
22 Chen J, Wu M, Liu R, Li S, Gao R, Song B. Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis. PLoS One 2015;10:e0117661. [PMID: 25658359 DOI: 10.1371/journal.pone.0117661] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
23 Li J, Zhou Y, Liu Y, Dai B, Zhang YH, Zhang PF, Shi XL. Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma. Cancer Biol Ther. 2018;1-8. [PMID: 30277836 DOI: 10.1080/15384047.2018.1480280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Santos NP, Colaço AA, Oliveira PA. Animal models as a tool in hepatocellular carcinoma research: A Review. Tumour Biol 2017;39:1010428317695923. [PMID: 28347231 DOI: 10.1177/1010428317695923] [Cited by in Crossref: 46] [Cited by in F6Publishing: 54] [Article Influence: 9.2] [Reference Citation Analysis]
25 Zhang L, Jiang G, Yao F, He Y, Liang G, Zhang Y, Hu B, Wu Y, Li Y, Liu H. Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma. PLoS One 2012;7:e37865. [PMID: 22662241 DOI: 10.1371/journal.pone.0037865] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
26 Huang D, Yang B, Yao Y, Liao M, Zhang Y, Zeng Y, Zhang F, Wang N, Tong G. Autophagic Inhibition of Caveolin-1 by Compound Phyllanthus urinaria L. Activates Ubiquitination and Proteasome Degradation of β-catenin to Suppress Metastasis of Hepatitis B-Associated Hepatocellular Carcinoma. Front Pharmacol 2021;12:659325. [PMID: 34168559 DOI: 10.3389/fphar.2021.659325] [Reference Citation Analysis]
27 Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT, Tsung A. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology. 2012;55:1863-1875. [PMID: 22234969 DOI: 10.1002/hep.25572] [Cited by in Crossref: 161] [Cited by in F6Publishing: 152] [Article Influence: 16.1] [Reference Citation Analysis]
28 Hu B, An HM, Shen KP, Xu L, DU Q, Deng S, Wu Y. Liver Yin deficiency tonifying herbal extract induces apoptosis and cell senescence in Bel-7402 human hepatocarcinoma cells. Exp Ther Med. 2012;3:80-86. [PMID: 22969849 DOI: 10.3892/etm.2011.364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
29 Liu TQ, Fan J, Zhou L, Zheng SS. Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int 2011;10:72-7. [PMID: 21269938 DOI: 10.1016/s1499-3872(11)60010-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
30 Wu L, Pang Y, Qin G, Xi G, Wu S, Wang X, Chen T. Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives. PLoS One 2017;12:e0171840. [PMID: 28182780 DOI: 10.1371/journal.pone.0171840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Surov A, Pech M, Omari J, Fischbach F, Damm R, Fischbach K, Powerski M, Relja B, Wienke A. Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma. Liver Cancer 2021;10:10-24. [PMID: 33708636 DOI: 10.1159/000511384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Liu C, Li F, Li X, Cao M, Feng G, Yuan X, Shi X. WIPI2 depletion inhibits the growth of hepatocellular carcinoma cells through the AMPK signaling pathway. Oncol Rep 2020;43:1467-78. [PMID: 32323845 DOI: 10.3892/or.2020.7531] [Reference Citation Analysis]
33 Hu B, An HM, Shen KP, Song HY, Deng S. Polygonum cuspidatum Extract Induces Anoikis in Hepatocarcinoma Cells Associated with Generation of Reactive Oxygen Species and Downregulation of Focal Adhesion Kinase. Evid Based Complement Alternat Med. 2012;2012:607675. [PMID: 23008742 DOI: 10.1155/2012/607675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
34 Kenngott HG, Pfeiffer M, Preukschas AA, Bettscheider L, Wise PA, Wagner M, Speidel S, Huber M, Nickel F, Mehrabi A, Müller-Stich BP. IMHOTEP: cross-professional evaluation of a three-dimensional virtual reality system for interactive surgical operation planning, tumor board discussion and immersive training for complex liver surgery in a head-mounted display. Surg Endosc 2021. [PMID: 33475848 DOI: 10.1007/s00464-020-08246-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 An HM, Xue YF, Shen YL, Du Q, Hu B. Sodium valproate induces cell senescence in human hepatocarcinoma cells. Molecules 2013;18:14935-47. [PMID: 24304587 DOI: 10.3390/molecules181214935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]